Spears Abacus Advisors LLC Abbott Laboratories Transaction History
Spears Abacus Advisors LLC
- $4.73 Billion
- Q3 2024
A detailed history of Spears Abacus Advisors LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Spears Abacus Advisors LLC holds 590,508 shares of ABT stock, worth $66.6 Million. This represents 1.42% of its overall portfolio holdings.
Number of Shares
590,508
Previous 355,468
66.12%
Holding current value
$66.6 Million
Previous $36.9 Million
82.27%
% of portfolio
1.42%
Previous 0.8%
Shares
14 transactions
Others Institutions Holding ABT
# of Institutions
3,186Shares Held
1.3BCall Options Held
8.74MPut Options Held
8.08M-
Vanguard Group Inc Valley Forge, PA168MShares$18.9 Billion0.35% of portfolio
-
Black Rock Inc. New York, NY131MShares$14.8 Billion0.31% of portfolio
-
State Street Corp Boston, MA76.7MShares$8.65 Billion0.36% of portfolio
-
Capital International Investors Los Angeles, CA65.7MShares$7.42 Billion1.49% of portfolio
-
Capital Research Global Investors Los Angeles, CA53.3MShares$6.01 Billion1.31% of portfolio
About ABBOTT LABORATORIES
- Ticker ABT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,751,219,968
- Market Cap $198B
- Description
- Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...